Rapid endoglin determination in serum samples using an amperometric magneto-actuated disposable immunosensing platform
Loading...
Official URL
Full text at PDC
Publication date
2016
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Citations
Exportar
Citation
Torrente-Rodríguez RM, Campuzano S, Ruiz-Valdepeñas-Montiel V, Pedrero M, Fernández-Aceñero MJ, Barderas R, Pingarrón JM. Rapid endoglin determination in serum samples using an amperometric magneto-actuated disposable immunosensing platform. J Pharm Biomed Anal. 2016 Sep 10;129:288-293. doi: 10.1016/j.jpba.2016.07.020. Epub 2016 Jul 15. PMID: 27448312.
Abstract
A sensitive and rapid method for the determination of the clinically relevant biomarker human endoglin (CD105) in serum samples is presented, involving a magneto-actuated immunoassay and amperometric detection at disposable screen-printed carbon electrodes (SPCEs). Micro-sized magnetic particles were modified with a specific antibody to selectively capture the target protein which was further sandwiched with a secondary HRP-labeled antibody. The immunocomplexes attached to the magnetic carriers were amperometrically detected at SPCEs using the hydroquinone (HQ)/H2O2/HRP system. The magneto-actuated immunosensing platform was able to detect 5 pmoles of endoglin (in 25μL of sample, 0.2μM) in 30min providing statistically similar results to those obtained using a commercial ELISA kit for the determination of endogenous content of endoglin in human serum samples.